01/04/2008
Linfoma MALT: è possible la strategia del watch and wait?
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wündisch T, Neubauer A, Raderer M, Savio A; EGILS (European Gastro-Intestinal Lymphoma Study) Group. Gut. 2007 Dec;56(12):1685-7.
29/03/2008
SCOPERTO NUOVO MARKER PROGNOSTICO PER K COLON
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaAaron J. Schetter; Suet Yi Leung; Jane J. Sohn; Krista A. Zanetti; Elise D. Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L. W. Kwong; Gordon K. H. Au; Chang-Gong Liu; George A. Calin; Carlo M. Croce; Curtis C. Harris. JAMA. 2008;299(4):425-436.
17/03/2008
Clinical cancer advances 2007 segnalate da ASCO
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the american society of clinical oncology.Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL, Lichter AS; American Society of Clinical Oncology. J Clin Oncol. 2008 Jan 10;26(2):313-25.
10/03/2008
CAPECITABINA efficace per K gastrico
Capecitabine and oxaliplatin for advanced esophagogastric cancer.Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom.N Engl J Med. 2008 Jan 3;358(1):36-46.
10/03/2008
CAPECITABINA efficace per K gastrico
Capecitabine and oxaliplatin for advanced esophagogastric cancer.Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom.N Engl J Med. 2008 Jan 3;358(1):36-46.
04/03/2008
Cl.WHO per tumori endocrini del pancreas: si può semplificare?
Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? Ferrone CR, Tang LH, Tomlinson J, Gonen M, Hochwald SN, Brennan MF, Klimstra DS, Allen PJ. J Clin Oncol. 2007 Dec 10;25(35):5609-15.
03/03/2008
Modello prognostico per la valutazione del K colon (stage II)
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A. Cancer. 2007 Dec 12 [Epub ahead of print]
29/02/2008
Quale trattamento chirurgico nelle occlusioni da K colon sinistro?
Systematic evaluation of surgical strategies for acute malignant left-sided colonic obstruction. Breitenstein S, Rickenbacher A, Berdajs D, Puhan M, Clavien PA, Demartines N. Br J Surg. 2007 Dec;94(12):1451-60.
23/02/2008
Meta-analisi sul trattamento locoregionale delle meta epatiche da K colon
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? Mocellin S, Pilati P, Lise M, Nitti D. J Clin Oncol. 2007 Dec 10;25(35):5649-54.
16/02/2008
PPI e rischio di K colon : nessuna associazione
Proton Pump Inhibitors and the Risk of Colorectal Cancer. van Soest EM, van Rossum LG, Dieleman JP, van Oijen MG, Siersema PD, Sturkenboom MC, Kuipers EJ. Am J Gastroenterol. 2007 Dec 5 [Epub ahead of print]
25/01/2008
CANCRO COLORETTALE: IL CETUXIMAB MIGLIORA LA SOPRAVVIVENZA
Cetuximab for the Treatment of Colorectal Cancer.Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ. N Engl J Med. 2007 Nov 15;357(20):2040-2048.
15/01/2008
CANCRO COLON, VITAMINA D RIDUCE IL RISCHIO DI MORTE
Prospective study of serum vitamin D and cancer mortality in the United States. Freedman DM, Looker AC, Chang SC, Graubard BI. J Natl Cancer Inst. 2007 Nov 7;99(21):1594-602
05/01/2008
Nuova chemioterapia per K gastrico
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineShinichi Sakuramoto, Mitsuru Sasako,Toshiharu Yamaguchi, Taira Kinoshita, Masashi Fujii, Atsushi Nashimoto, Hiroshi Furukawa, Toshifusa Nakajima, Yasuo Ohashi, Hiroshi Imamura, Masayuki Higashino, Yoshitaka Yamamura, Akira Kurita, Kuniyoshi Arai, for the ACTS-GC Group. N Engl J Med 2007 Nov 1; 357:1810.